Although some scholars have studied the differential expression of SLC mRNA in ccRCC, it was found that SLC10A2 was significantly downregulated in TKI-treated samples and SLC10A2 was upregulated in ccRCC compared with adjacent kidney tissues in paired The Cancer Genome Atlas (TCGA) samples. The gene discussed is CCL21; the disease is nonpapillary renal cell carcinoma.